Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003471786 | SCV004206092 | likely pathogenic | Fetal akinesia deformation sequence 2 | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003779088 | SCV004590266 | pathogenic | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2022-12-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RAPSN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys97Alafs*31) in the RAPSN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAPSN are known to be pathogenic (PMID: 17686188). |